<code id='F0A25E6378'></code><style id='F0A25E6378'></style>
    • <acronym id='F0A25E6378'></acronym>
      <center id='F0A25E6378'><center id='F0A25E6378'><tfoot id='F0A25E6378'></tfoot></center><abbr id='F0A25E6378'><dir id='F0A25E6378'><tfoot id='F0A25E6378'></tfoot><noframes id='F0A25E6378'>

    • <optgroup id='F0A25E6378'><strike id='F0A25E6378'><sup id='F0A25E6378'></sup></strike><code id='F0A25E6378'></code></optgroup>
        1. <b id='F0A25E6378'><label id='F0A25E6378'><select id='F0A25E6378'><dt id='F0A25E6378'><span id='F0A25E6378'></span></dt></select></label></b><u id='F0A25E6378'></u>
          <i id='F0A25E6378'><strike id='F0A25E6378'><tt id='F0A25E6378'><pre id='F0A25E6378'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:2723
          Good CEOs 2022
          Hyacinth Empinado/STAT

          It’s that time of the year again when I recognize the Best Biopharma CEO of the year.

          This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

          advertisement

          What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          GSK’s asthma push continues as drug succeeds in Phase 3 trials
          GSK’s asthma push continues as drug succeeds in Phase 3 trials

          AkiraSuemori/APAnewasthmatreatmentthatcouldbeadministeredjustonceeverysixmonthshassucceededintwoPhas

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          How one patient went off dialysis — and others can too

          Melissa“Liddy”LawsonphotographedinSanFrancisco,whereshewashospitalizedfornearlysixmonths.ConstanzaHe